-
Just 18% of 5- to 11-year-olds are fully vaccinated, with rates varying significantly across the country, a KHN analysis of federal data shows. Pediatricians say the slow pace and geographic disparities are alarming.
-
At least three promising antiviral treatments for COVID-19 are being tested in clinical trials, with results expected as soon as late fall or winter.
-
More than 100 bills have been introduced in 42 states this year to regulate these companies, which serve as conduits for drug manufacturers, health insurers and pharmacies.
-
The final plan clears the way for Florida and other states to implement a program bringing medications across the border despite the strong objections of drugmakers and the Canadian government.
-
In the United States and other developed nations, the solution to drug-company reluctance was to shower them with billions of dollars in public funds to persuade them to help.
-
Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies' reputations. Litigation has forced the release of internal documents that are shifting the narrative.
-
The Senate Health Policy Committee on Monday unanimously signed off on a pair of bills sponsored by the panel’s chairwoman, Gayle Harrell.
-
Researchers sketched a vivid line Friday linking the dollars spent by drugmakers to woo doctors around the country to a vast opioid epidemic that has...
-
House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the...